Patents by Inventor Michael Kent Morgan

Michael Kent Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6281413
    Abstract: Novel nucleic acid sequences isolated from Photorhabdus luminescens, whose expression results in novel insecticidal toxins, are disclosed herein. The invention also discloses compositions and formulations containing the insecticidal toxins that are capable of controlling insect pests. The invention is further drawn to methods of making the toxins and to methods of using the nucleotide sequences, for example in microorganisms to control insect pests or in transgenic plants to confer insect resistance.
    Type: Grant
    Filed: February 17, 1999
    Date of Patent: August 28, 2001
    Assignee: Syngenta Participations AG
    Inventors: Vance Cary Kramer, Michael Kent Morgan, Arne Robert Anderson, Hope Prim Hart, Gregory W. Warren, Martha M. Dunn, Jeng Shong Chen
  • Patent number: 6277823
    Abstract: Novel nucleic acid sequences isolated from Xenorhabdus nematophilus, Xenorhabdus poinarii, and Photorhabdus luminescens, whose expression results in novel insecticidal toxins, are disclosed herein. The invention also discloses compositions and formulations containing the insecticidal toxins that are capable of controlling insect pests. The invention is further drawn to methods of making the toxins and to methods of using the nucleotide sequences, for example in microorganisms to control insect pests or in transgenic plants to confer insect resistance.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: August 21, 2001
    Assignee: Syngenta Participations AG
    Inventors: Vance Cary Kramer, Michael Kent Morgan, Arne Robert Anderson
  • Patent number: 6174860
    Abstract: Novel nucleic acid sequences isolated from Xenorhabdus nematophilus, Xenorhabdus poinarii, and Photorhabdus luminescens, whose expression results in novel insecticidal toxins, are disclosed herein. The invention also discloses compositions and formulations containing the insecticidal toxins that are capable of controlling insect pests. The invention is further drawn to methods of making the toxins and to methods of using the nucleotide sequences, for example in microorganisms to control insect pests or in transgenic plants to confer insect resistance.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: January 16, 2001
    Assignee: Novartis AG
    Inventors: Vance Cary Kramer, Michael Kent Morgan, Arne Robert Anderson